Endocrine Abstracts

GH is now well recognised as therapeutic modality for treatment of adult patients with documented GH deficiency, and long-term experience is being gathered. This has, however, revealed also several therapeutic dilemmas, which clinicians managing these patients need to be aware of. Some of these examples are: What to do in case of brain tumours/meningeomas? What to do in patients with concomitant diabetes mellitus with and without complications? How do we handle the patient with previous acromegaly? And how do we manage the patient with recurrent pituitary adenomas? The presentation will be based on patient cases as illustration and documentation of available evidence from current litterature and own experience.